We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cvs Group Plc | LSE:CVSG | London | Ordinary Share | GB00B2863827 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.00 | 0.10% | 976.00 | 981.00 | 983.00 | 991.00 | 970.00 | 970.00 | 215,662 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Veterinary Svcs-animal Specs | 608.3M | 41.9M | 0.5843 | 16.79 | 703.5M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/9/2023 07:57 | Yeap, CMA stated some time in 2024 IIRC? | bulltradept | |
21/9/2023 07:46 | (Bloomberg) -- CVS Group reported adjusted Ebitda for the full year that beat the average analyst estimate. YEAR RESULTS * Adjusted Ebitda GBP121.4 million, estimate GBP117.9 million (Bloomberg Consensus) * Revenue GBP608.3 million, estimate GBP606.2 million * Dividend per share 7.5p vs. 7.0p y/y * Adjusted EPS 96p, estimate 92p * Pretax profit GBP53.9 million, estimate GBP58.2 million * Adjusted pretax profit GBP85.4 million, estimate GBP83.2 million * Operating profit GBP62.3 million, estimate GBP64.7 million * Net cash from oper. activities GBP84.5 million, estimate GBP80.1 million Little commentary re CMA- I'm presuming because they're in the dark as much as we are? | se81 | |
21/9/2023 07:43 | Dividends In light of the continued growth of the Group and its positive operating cash generation, the Board is recommending a continuation of our progressive dividend policy, with the payment of a final dividend of 7.5p per Ordinary share (2022: 7.0p). The ex-dividend date is 2 November 2023 and the dividend payment date is 8 December 2023. | ariane | |
21/9/2023 07:37 | Smashed results. As expected. Expect some nice bod buys today. | babbler | |
14/9/2023 16:25 | London Stock Exchange 12:09:12 2023-09-14 pm CVS Group plc 1491.00 GBX +0.07% | adrian j boris | |
14/9/2023 16:23 | RBC raises CVS Group to 'outperform' (sector perform) - price target 1,900 (2,200) pence | adrian j boris | |
14/9/2023 16:22 | RBC Upgrades CVS Group to Outperform from Sector Perform, Lowers PT September 13, 2023 at 07:55 am EDT (MT Newswires) -- RBC on Wednesday upgraded its recommendation on CVS Group (CVSG.L) to outperform from sector perform and reduced its price target to 19.00 pounds sterling from 22.00 pounds. | adrian j boris | |
14/9/2023 09:04 | lol to what? Let's see what the resutls brings. | bulltradept | |
13/9/2023 17:45 | Bulltradept - LOL | roddyb | |
11/9/2023 11:17 | Yes. It was in the rns they released last week. | babbler | |
11/9/2023 11:12 | Financial calendar Thursday 21st September 2023 – Preliminary results | gibbs1 | |
11/9/2023 11:10 | It's neither. It's profit taking from the dip to 1400 last week. | babbler | |
11/9/2023 10:34 | Which ever it is, people are still going to pay for their pets. BUY. | bulltradept | |
11/9/2023 10:13 | Still more share price weakness ,I wonder if this is slow news circulation, or more concern about margins. | wad collector | |
07/9/2023 16:20 | Long way to go yet still 16% down but give it another 2 or 3 trading days... | babbler | |
07/9/2023 16:03 | Oh look, it's recovered, there's a surprise, not. ;-) | bulltradept | |
07/9/2023 15:43 | They will make recommendations. It's.more about transparency from what I'm reading. Who knows but 1480 was lovely price to get in at today (missed the low had to do some reading). | babbler | |
07/9/2023 15:37 | There will be more trees felled for the report and implementing its recommendations̷ It is like private medicine…..ava A few areas where the CMA may look: Relationships with Pet Insurers (and the effect on self payers) Drug pricing…(witho Healthy pet clubs too - but maybe customers should be able to work out for themselves if they get value for money. | 1jat | |
07/9/2023 13:21 | People will forget the news by the end of September. 2024 is a while away. CMA won't really do much anyway. They let Asda takeover through without flinching. That led to fuel price competition going. They will look at prices and probably blame inflation and staff costs and say not a lot can be done. If anything else is to go by it will just lead to prices rising. | babbler | |
07/9/2023 11:40 | Michele Maatouk Sharecast News 07 Sep, 2023 09:35 07 Sep, 2023 09:41 Pets at Home, CVS tumble as CMA launches review of vet services Shares of Pets at Home and CVS Group tumbled on Thursday after the Competition and Markets Authority said it was launching a probe into the £2bn veterinary services market for household pets. The competition watchdog said it will explore how well the market is working for pet owners and whether they are receiving the information they need at the right time to get appropriate treatment for their pets. The CMA said it was keen to hear more about pet owners’ and vet practitioners’ experiences of pricing of services, including whether pet owners were aware of how much a treatment would cost, and how they pay for it. It also wants to hear about how prescriptions and medication for pets are arranged and sold and how pet owners choose a vet surgery - whether they are aware that their vet may be part of a larger chain which might also own other surgeries in the area. The use of out-of-hours and emergency vet services where options might be limited will also be looked into. CMA chief executive Sarah Cardell said: "Caring for an ill pet can create real financial pressure, particularly alongside other cost of living concerns. It’s really important that people get clear information and pricing to help them make the right choices. "There has been a lot of consolidation in the vet industry in recent years, so now is the right time to take a look at how the market is working. "When a pet is unwell, they often need urgent treatment, which means that pet owners may not shop around for the best deal, like they do with other services. This means they may not have the relevant information to make informed decisions at what can be a distressing time. We want to hear from pet owners and people who work in the sector about their experiences." Pets at Home owns veterinary groups Companion Care Vets and Vets4Pets and has a network of more than 450 vet practices across the UK. CVS Group, meanwhile, is one of the largest integrated veterinary services providers in the UK. At 0925 BST, Pets shares were down 11.2% at 336.20p. Shares of AIM-listed vet services provider CVS Group were down 29% at 1,479.00p. Russ Mould, investment director at AJ Bell, said: "Being in the pets and vet space has felt like a healthy place to be in recent years. That’s been reflected in strong share prices for the likes of vet group CVS and Pets at Home which has its own veterinary arm within a broader retail and grooming offering. "Britons love their animal companions and are willing to pay up to keep them healthy and happy. "News that the competition authorities are looking into the rising costs and potentially anti-competitive practices in the industry has set the cat among the pigeons when it comes to the share prices of CVS and Pets at Home. "The sell-off seen today could be an overreaction, although the CMA review looks to be wide-ranging. The problem for both businesses is the process is likely to be time-consuming and, with a further update not due until early 2024, it could weigh on both stocks for some time to come." | maywillow | |
07/9/2023 11:06 | Response to CMA review into the veterinary services market CVS, the UK quoted veterinary group and a leading provider of integrated veterinary services, notes that the Competition and Markets Authority ("CMA") has launched a review into the UK veterinary services market for household pets. We always work closely with our regulators and we and our colleagues will support the CMA review. Our purpose at CVS is to give the best possible care to animals and we continually invest in our colleagues, practices and clinical equipment to enhance the care to our clients and their patients. The Group has always sought to ensure its prices are appropriate and reflect fair value to our clients. Our pricing structures are set by clinicians to ensure these align with our purpose. As the CMA have recognised, there continues to be a significant shortage of vets in the UK and employment costs represent the most significant proportion of our cost base. Our pricing reflects this and other inflationary pressures experienced in recent years. We have a clear strategy to continue to expand our network and to improve clinical care through investment in facilities, equipment, technology and our people. | ariane | |
07/9/2023 11:06 | Exactly what they just said. There you go. | babbler | |
07/9/2023 11:02 | RNS by CVS out , result on 21/9 | jaws6 | |
07/9/2023 10:04 | Dechra take over may be called in | robertball | |
07/9/2023 09:48 | Babbler, what can they say? You'll get more sense from people's musings here atm as there's nothing to go on. | bulltradept |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions